Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
KIF18A INHIBITOR COMPOUND, AND PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/051755
Kind Code:
A1
Abstract:
The present invention provides a compound as represented by formula (I), and a pharmaceutical composition and a preparation method therefor and a use thereof. The compound has a good inhibitory effect on KIF18A, and can be used alone or in combination with microtubules to form a bonded complex to modulate a KIF18A protein for treatment of KIF18A-mediated conditions and/or diseases, such as tumors, and for preparation of a drug for such conditions or diseases.

Inventors:
LU BIAO (CN)
YANG FANGLONG (CN)
ZHANG CHEN (CN)
WANG SIQIN (CN)
JIN LEI (CN)
Application Number:
PCT/CN2023/117322
Publication Date:
March 14, 2024
Filing Date:
September 06, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D401/12; A61K31/438; A61K31/4427; A61P35/00; C07D401/14
Domestic Patent References:
WO2023174175A12023-09-21
WO2021026099A12021-02-11
Foreign References:
CN107398300A2017-11-28
CN114302880A2022-04-08
CN113226473A2021-08-06
Other References:
ROANE JAMES, DAUGULIS OLAFS: "A General Method for Aminoquinoline-Directed, Copper-Catalyzed sp 2 C–H Bond Amination", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, vol. 138, no. 13, 6 April 2016 (2016-04-06), pages 4601 - 4607, XP093147821, ISSN: 0002-7863, DOI: 10.1021/jacs.6b01117
DATABASE REGISTRY CAS; 8 November 2021 (2021-11-08), ANONYMOUS : "3-Pyridinecarboxamide, N-9H-fl uoren-9-yl-2-(4-methyl-1-pip erazinyl)-6- (tetrahydro-2-thienyl)-", XP093147823, retrieved from STN Database accession no. 2726653-65-0
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: